Denise Braendgaard: OneSCD Brings Sickle Cell Disease to the Global Stage
Denise Braendgaard, General Manager at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared a post on LinkedIn, adding:
“The launch of OneSCD at the United Nations General Assembly UNGA81 marks an important milestone for the sickle cell disease community.
For me, OneSCD brings the full circle into focus: local realities, continental collaboration, global alignment and country-led action.
Just three weeks ago, I was in Dar es Salaam, Tanzania, with our partners from Tanzania and other key African countries carrying a high burden of sickle cell disease, celebrating the launch of the partnership between Africa CDC and the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation (NNHF) for the implementation of the Continental Plan for Sickle Cell Disease and Other Inherited Blood Disorders.
Now, OneSCD brings this country and continental momentum to the global stage.
Global alignment matters, and lasting impact happens at country level. Countries most affected must have a meaningful voice in shaping priorities and solutions. At NNHF, we will continue working alongside governments, partners and communities to translate shared priorities into locally led, sustainable action.
One message is clear: where a person lives should not determine whether they can access diagnosis, quality care and treatment.
Thank you to the Government of the Federal Republic of Nigeria, St. Jude Children’s Research Hospital, World Health Organization, UNICEF, Africa CDC, World Coalition on Sickle Cell Disease (WCSCD) and all partners for your leadership in bringing this community together and advancing global alignment on sickle cell disease!”
Other posts featuring Denise Braendgaard on Hemostasis Today.
-
Nov 16, 2026, 10:08Abdul Mannan: When Normal Blood Counts Hide Iron Deficiency
-
Nov 16, 2026, 09:47Ankit Kumar: A Memorable Experience at Haematocon 2026
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease